Gladius Capital Management’s Amgen AMGN Stock Holding History

Gladius Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,100	Closed	-$317K	–	314
2023 Q4	$317K	Buy	+1,100	New	+$300K	0.05%	116
2022 Q1	–	Sell	-1,300	Closed	-$293K	–	270
2021 Q4	$293K	Hold	1,300	–	–	0.02%	151
2021 Q3	$277K	Hold	1,300	–	–	0.02%	92
2021 Q2	$317K	Sell	1,300 -24,200	-95%	-$5.95M	0.03%	95
2021 Q1	$6.34M	Buy	25,500 +2,100	+9%	+$501K	0.24%	91
2020 Q4	$5.38M	Buy	23,400 +19,900	+569%	+$4.59M	0.27%	91
2020 Q3	$890K	Buy	+3,500	New	+$867K	0.09%	97
2020 Q2	–	Sell	-4,400	Closed	-$893K	–	19
2020 Q1	$893K	Sell	4,400 -3,100	-41%	-$677K	0.09%	97
2019 Q4	$1.81M	Buy	7,500 +2,000	+36%	+$441K	0.11%	109
2019 Q3	$1.06M	Buy	5,500 +3,400	+162%	+$653K	0.05%	157
2019 Q2	$392K	Buy	+2,100	New	+$376K	0.02%	142

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Gladius Capital Management's AMGN Position: Q3 2024 in Review

Gladius Capital Management sold out of Amgen (AMGN) in Q3 2024, closing a stake of 1,328 shares — an estimated $415K sold.

Gladius Capital Management first reported a position in AMGN in Q4 2018 and held it in 13 quarters. The position peaked at $3.51M in Q4 2018. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

Gladius Capital Management reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
Gladius Capital Management sold 1,328 Amgen shares in Q3 2024, an estimated $415K.
Gladius Capital Management first reported a position in Amgen in Q4 2018 and held it in 13 quarters.
Gladius Capital Management's Amgen position peaked at $3.51M in Q4 2018.
2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Gladius Capital Management's 13F filing for Q3 2024, filed 6 Nov 2024.